377 related articles for article (PubMed ID: 2497184)
1. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
[TBL] [Abstract][Full Text] [Related]
3. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
[TBL] [Abstract][Full Text] [Related]
4. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
Cowan MJ; Shannon KM; Wara DW; Ammann AJ
Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 2 responsive lymphocytes in patients with adenosine deaminase deficiency.
Cowan MJ; Smith W; Ammann AJ
Clin Immunol Immunopathol; 1989 Oct; 53(1):59-67. PubMed ID: 2569954
[TBL] [Abstract][Full Text] [Related]
6. Severe combined immunodeficiency in a child with a healthy adenosine deaminase deficient mother.
Schmalstieg FC; Mills GC; Tsuda H; Goldman AS
Pediatr Res; 1983 Dec; 17(12):935-40. PubMed ID: 6606796
[TBL] [Abstract][Full Text] [Related]
7. Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
Sawami H; Toyokawa Y; Ito K; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):721-9. PubMed ID: 2618547
[TBL] [Abstract][Full Text] [Related]
8. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine.
Hirschhorn R; Bajaj S; Borkowsky W; Kowalski A; Hong R; Rubinstein A; Papageorgiou P
Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698
[No Abstract] [Full Text] [Related]
10. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.
Kantoff PW; Kohn DB; Mitsuya H; Armentano D; Sieberg M; Zwiebel JA; Eglitis MA; McLachlin JR; Wiginton DA; Hutton JJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6563-7. PubMed ID: 3489233
[TBL] [Abstract][Full Text] [Related]
11. Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
Adrian GS; Hutton JJ
J Clin Invest; 1983 Jun; 71(6):1649-60. PubMed ID: 6134754
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
Kubota M; Kamatani N; Daddona PE; Carson DA
Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of deoxyribonucleotides as a possible mediator of immunosuppression in hereditary deficiency of adenosine deaminase.
Bluestein HG; Willis RC; Thompson LF; Matsumoto S; Seegmiller JE
Trans Assoc Am Physicians; 1978; 91():394-402. PubMed ID: 314193
[No Abstract] [Full Text] [Related]
14. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
[TBL] [Abstract][Full Text] [Related]
15. Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.
Valerio D; Duyvesteyn MG; van Ormondt H; Meera Khan P; van der Eb AJ
Nucleic Acids Res; 1984 Jan; 12(2):1015-24. PubMed ID: 6198631
[TBL] [Abstract][Full Text] [Related]
16. Purine metabolism in adenosine deaminase deficiency.
Simmonds HA; Sahota A; Potter CF; Perrett D; Hugh-Jones K; Watson JG
Ciba Found Symp; 1978; (68):255-62. PubMed ID: 387357
[TBL] [Abstract][Full Text] [Related]
17. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
Uberti J; Peterson WD; Lightbody JJ; Johnson RM
J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
[TBL] [Abstract][Full Text] [Related]
18. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
Donofrio J; Coleman MS; Hutton JJ; Daoud A; Lampkin B; Dyminski J
J Clin Invest; 1978 Oct; 62(4):884-7. PubMed ID: 308954
[TBL] [Abstract][Full Text] [Related]
19. Influence of adenosine deaminase inhibition on the phosphoinositide turnover in the initial stages of human T cell activation.
Buc HA; Moncion A; Hamet M; Houllier AM; Thuilier L; Perignon JL
Eur J Immunol; 1990 Mar; 20(3):611-5. PubMed ID: 2156710
[TBL] [Abstract][Full Text] [Related]
20. Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency.
Markert ML; Hershfield MS; Wiginton DA; States JC; Ward FE; Bigner SH; Buckley RH; Kaufman RE; Hutton JJ
J Immunol; 1987 May; 138(10):3203-6. PubMed ID: 3571974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
